Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GNRC | DOV |
|---|---|---|
| Price | $206.39 | $187.35 |
| Change today | ▼ 0.27% | ▲ 0.16% |
| Market cap | $12.19B | $25.23B |
| Return, 3 months | -23.6% | -13.5% |
| Return, year to date | +51.3% | -3.3% |
| Return, 1 year | +22.9% | +13.8% |
| P/E (TTM) | 47.4 | 22.5 |
| P/B | 4.2 | 3.3 |
| P/E percentile vs own 5y | 81st | 78th |
| Dividend yield | – | 1.11% |
| Revenue growth (YoY, latest qtr) | +10.6% | +6.9% |
| Net profit growth (YoY) | +92.1% | +11.9% |
| Gross margin | 39.5% | 39.6% |
| Operating margin | 9.5% | 16.9% |
| Net margin | 5.8% | 13.5% |
| Return on equity | 9.5% | 15.0% |
| Analyst target vs. price | +43.3% | +32.3% |
| Analyst buy share | 71% | 80% |
| RSI (14) | 55 | 39 |
| 30-day volatility | 65.2% | 18.6% |
| Max drawdown, 1 year | -40.8% | -19.6% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
